Merck KGaA, Darmstadt, Germany, Launches Seed Fund for Startups in China

Merck KGaA, Darmstadt, Germany, today announced an RMB 100 million (€ 13 million) seed fund targeted at startups in China. The company also officially opened its innovation hub in Shanghai and announced… 18 OCT 2019 | DARMSTADT, GERMANY RMB 100 million fund targets startups close to the three business sectors of Merck KGaA, Darmstadt, Germany, as well... Read more

Xylem Inc. Declares Fourth Quarter Dividend of 24 Cents Per Share

RYE BROOK, N.Y.–(BUSINESS WIRE)–Oct. 17, 2019– The Board of Directors of Xylem Inc. (NYSE: XYL) has declared a third quarter dividend of $0.24 per share payable on December 5, 2019 to shareholders of record as of October 31, 2019. Xylem is a leading global water technology company committed to developing innovative technology solutions to the... Read more

Xylem to release third quarter 2019 financial results on October 31, 2019

RYE BROOK, N.Y.–(BUSINESS WIRE)–Oct. 17, 2019– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, will release its third quarter 2019 results at 6:55 a.m. (ET) on Thursday, October 31, 2019. At 9:00 a.m. (ET), Xylem’s senior management team will host a conference call with... Read more

New reporting structure – historic financials

16 October 2019 – Spectris plc (‘Spectris’) (LSE: SXS), the productivity-enhancing instrumentation and controls company, today issues summary historic financial information for its new reporting structure. At its half year results, the Group announced that it had changed its reporting structure from 1 July 2019 and reclassified its segmental reporting. It will now disclose financial... Read more

New Head of ZEISS Research Microscopy Solutions

Topics Press Release About ZEISS Further Articles Jena, Germany | 15 October 2019 | ZEISS Research Microscopy Solutions Effective 1 October 2019, Dr. Michael Albiez became Head of the Research Microscopy Solutions strategic business unit (RMS SBU) at ZEISS and, with this appointment, a Member of the Management Team for the ZEISS Industrial Quality & Research... Read more

Agilent Early Career Professor Award Presented to Saeed Hassanpour

Agilent Early Career Professor Award Presented to Saeed Hassanpour Dartmouth College professor recognized for application of artificial intelligence to histopathology SANTA CLARA, Calif., October 14, 2019 Agilent Technologies, Inc. (NYSE: A) today announced that Saeed Hassanpour, Ph.D., has received the 2019 Agilent Early Career Professor Award (AECPA). Dr. Hassanpour is a member at the Dartmouth-... Read more

Phase III PEMPHIX study shows Roche’s MabThera/Rituxan (rituximab) superior to mycophenolate mofetil in patients with pemphigus vulgaris

Basel, 14 October 2019 Phase III PEMPHIX study shows Roche’s MabThera/Rituxan (rituximab) superior to mycophenolate mofetil in patients with pemphigus vulgaris 40% of patients with pemphigus vulgaris (PV) achieved sustained complete remission, without the use of steroids for 16 weeks or more, when treated with MabThera/Rituxan compared to 9.5% of patients on mycophenolate mofetil Study... Read more

GE Healthcare Selected as Vendor of Choice for NYC Health + Hospitals $224 Million Investment to Upgrade Medical Imaging Technology System-Wide

230 medical imaging units will be replaced and updated within first four years Equipment will support the public health system’s goal of standardizing care and providing patients modernized, state-of-the-art imaging technology New York, NY – October 10, 2019 –NYC Health + Hospitals today announced that it is investing $224 million over ten-years to upgrade medical imaging technology... Read more

Highly Accurate SMRT Sequencing for Human Genetics to Be Showcased at ASHG 2019 Annual Meeting

MENLO PARK, Calif., Oct. 10, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that more than 50 presentations will include data from the company’s Single Molecule, Real-Time (SMRT®) sequencing platforms at next week’s American Society for Human Genetics (ASHG) 2019... Read more

Danaher Schedules Third Quarter 2019 Earnings Conference Call

WASHINGTON, Oct. 9, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2019 on Thursday, October 24, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of Danaher’s... Read more